scholarly journals The Impact of Body Weight Change on Bone Mineral Density of the Lumbar Spine in Perimenopausal Women: A Retrospective, One-year Follow-up Study

2011 ◽  
Vol 32 (4) ◽  
pp. 219 ◽  
Author(s):  
Ha-Rin Lee ◽  
Sung-Soo Hong ◽  
Sang-Yeoup Lee ◽  
Young-Hye Cho ◽  
Hyun-Ji Park ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Body Weight ◽  
Lumbar Spine ◽  
Body Weight Change ◽  
Mineral Density ◽  
Follow Up Study ◽  
Perimenopausal Women ◽  
One Year ◽  
The Impact

scholarly journals Body Weight and Body Mass Index Influence Bone Mineral Density in Late Adolescence in a Two‐Year Follow‐Up Study. The Tromsø Study: Fit Futures

JBMR Plus ◽  
2019 ◽  
Vol 3 (9) ◽  
Author(s):  
Ole Andreas Nilsen ◽  
Luai Awad Ahmed ◽  
Anne Winther ◽  
Tore Christoffersen ◽  
Gyrd Thrane ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Body Mass Index ◽  
Body Weight ◽  
Body Mass ◽  
Bone Mineral ◽  
Late Adolescence ◽  
Mineral Density ◽  
Follow Up Study

scholarly journals The Effects of Noncompliance to Prolia (Denosumab) on the Changes in Bone Mineral Density: A Retrospective Review

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Matthew Wong-Pack ◽  
Aashish Kalani ◽  
Jacob Hordyk ◽  
George Ioannidis ◽  
Robert Bensen ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Retrospective Review ◽  
Mineral Density ◽  
Eligibility Criteria ◽  
Multivariable Regression ◽  
One Year ◽  
The Impact ◽  
The Relationship

Although denosumab (Prolia) has been shown to be a safe and efficacious therapy for osteoporotic patients in numerous clinical trials, few studies have determined its effectiveness in real world clinical practice. A retrospective review of patients prescribed Prolia assessing the impact that noncompliance from the regular dosing regimen of six months for denosumab has on bone mineral density (BMD) was performed. 924 patient records were reviewed between August 2012 and September 2013 with 436 patients meeting the eligibility criteria. Patients were divided into three groups: subsequent injection of denosumab (1) less than five months, (2) between five and seven months, and (3) more than seven months after their initial subcutaneous injection. A multivariable regression analysis was conducted comparing the differences among the three prespecified groups in BMD change (g/cm2) after one year of denosumab therapy at both the lumbar spine (LS) and femoral neck (FN). The differences in LS and FN BMD have shown that the relationship between the timing of drug administration in these three groups and change in BMD over 1 year was not clinically or statistically significant (p>0.05). A follow-up study with a larger sample size and longer follow-up duration is required to further characterize this relationship.

An overview of body weight of older persons, including the impact on mortality The national health and nutrition examination survey i-epidemiologic follow-up study

1991 ◽  
Vol 44 (8) ◽  
pp. 743-753 ◽  
Author(s):  
Joan C. Cornoni-Huntley ◽  
Tamara B. Harris ◽  
Donald F. Everett ◽  
Demetrius Albanes ◽  
Marc S. Micozzi ◽  
...  
Keyword(s):  
Body Weight ◽  
National Health ◽  
Older Persons ◽  
Nutrition Examination Survey ◽  
Follow Up Study ◽  
Health And Nutrition ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document